-transparent.png){kind=logo}
Screening programs have expanded to identify the many persons who are unaware of their high blood cholesterol level and thus are at an increased risk for coronary heart disease. These programs bring both potential benefits and potential risks to the participant. One potential risk is that of iatrogenic effects of learning one's risk status, often referred to as the "labeling phenomenon." Research that has addressed the labeling phenomenon in blood pressure screening programs has important implications for blood cholesterol screenings. Detrimental effects on screening participants are possible, but they can be attenuated by careful attention to characteristics of the debriefing and counseling that should be included in screening protocols.
R C Lefebvre, and
K G Hursey, and
R A Carleton
March 1989,
Clinics in laboratory medicine,
R C Lefebvre, and
K G Hursey, and
R A Carleton
January 1989,
American journal of preventive medicine,
R C Lefebvre, and
K G Hursey, and
R A Carleton
November 2013,
Journal of clinical hypertension (Greenwich, Conn.),
R C Lefebvre, and
K G Hursey, and
R A Carleton
October 1990,
Patient education and counseling,
R C Lefebvre, and
K G Hursey, and
R A Carleton
March 1978,
Bulletin of the Eleventh District Dental Society,
R C Lefebvre, and
K G Hursey, and
R A Carleton
June 2009,
American family physician,
R C Lefebvre, and
K G Hursey, and
R A Carleton
April 1984,
Methods of information in medicine,
R C Lefebvre, and
K G Hursey, and
R A Carleton
January 1988,
JAMA,
R C Lefebvre, and
K G Hursey, and
R A Carleton
September 1987,
JAMA,
R C Lefebvre, and
K G Hursey, and
R A Carleton
January 1991,
Archives of internal medicine,
